Gastrointestinal, Endocrine, Nutrition & Blood Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £46K-£29M
- Sector
- HEALTH
- Published
- 25 Jul 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
46 suppliers
- Kent Pharmaceuticals Ashford
- Hameln Pharma Gloucester
- Panpharma Liverpool
- SVP Pharma Norwich
- Wockhardt Wrexham
- DR Falk Pharma Bucks
- Ferring Pharmaceuticals West Drayton
- Galen Craigavon
- Necessity Supplies Northolt
- Zydus Pharmaceuticals Bristol
- Martindale Pharma Romford
- Consilient Health Richmond
- Ennogen Healthcare Dartford
- Kyowa Kirin International Newco Galashiels
- Stirling Anglian Pharmaceuticals Glasgow
- Thornton & Ross Huddersfield
- Viatris UK Healthcare Hatfield
- Selective Supplies Haywards Heath
- Orphalan London
- Univar Solutions Cl Rotterdam
- Waymade Basildon
- Accord London
- Gedeon Richter London
- Ranbaxy London
- Teva Castleford
- Norgine Pharmaceuticals Uxbridge
- Glenmark Pharmaceuticals Europe Watford
- Pharmacosmos Reading
- Vifor Pharma Maidenhead
- Aventis Pharma Guildford
- Baxter Healthcare Berkshire
- Brown & Burk West London
- Colonis Pharma London
- Crescent Pharma Basingstoke
- CST Pharma Walsall
- DR Reddys Laboratories Cambridge
- Flynn Pharma Stevenage
- Focus Pharmaceuticals Burton upon Trent
- Mercury Pharmaceuticals London
- Morningside Pharmaceuticals Leicester
- Pfizer Tadworth
- Rosemont Pharmaceuticals Leeds
- RPH Pharma Cheadle
- Sandoz Camberley
- Typharm Norwich
- Otsuka Pharmaceuticals Windsor
Description
This Framework Agreement is for the supply of Gastrointestinal, Endocrine, Nutrition & Blood Medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Division
| 1 | Desferoxamine Injections Supply of Desferrioxamine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents. |
| 2 | Dexamethasone Injections Supply of Dexamethasone Injection to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 3 | Macrogol Oral Powder & Solutions Supply of Macrogol to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 4 | Mesalazine Oral/Rectal Preparations Supply of Mesalazine Oral/Rectal Preparations to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 5 | Magnesium Sulfate Injection Supply of Magnesium Sulfate Injection to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 6 | Colecalciferol & Calcium Carbonate Tablets Supply of Colecalciferol & Calcium Carbonate Tablets to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 7 | Budesonide Oral/Rectal Preparations Supply of Budesonide Oral/Rectal Preparations to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 9 | Trientine Tablets Supply of Trientine Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents. |
| 10 | Teriparatide Injections Supply of Teriparatide Injections to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents. |
| 11 | Tolvaptan Tablets Supply of Tolvaptan Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents. |
| 12 | Sapropterin & Deferasirox Tablets Supply of Sapropterin & Deferasirox Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents. |
| 13 | Intravenous (IV) Iron Supply of Intravenous (IV) Iron to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents. |
| 14 | Diabetes & Weight Management Supply of Diabetes & Weight Management to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents. |
| 15 | All Other Presentations Supply of All Other Presentations to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents. |
Award Detail
| 1 | Kent Pharmaceuticals (Ashford)
|
| 2 | Hameln Pharma (Gloucester)
|
| 3 | Panpharma (Liverpool)
|
| 4 | SVP Pharma (Norwich)
|
| 5 | Wockhardt (Wrexham)
|
| 6 | DR Falk Pharma (Bucks)
|
| 7 | Ferring Pharmaceuticals (West Drayton)
|
| 8 | Galen (Craigavon)
|
| 9 | Necessity Supplies (Northolt)
|
| 10 | Zydus Pharmaceuticals (Bristol)
|
| 11 | Martindale Pharma (Romford)
|
| 12 | SVP Pharma (Norwich)
|
| 13 | Consilient Health (Richmond)
|
| 14 | Ennogen Healthcare (Dartford)
|
| 15 | Galen (Craigavon)
|
| 16 | Kyowa Kirin International Newco (Galashiels)
|
| 17 | Stirling Anglian Pharmaceuticals (Glasgow)
|
| 18 | Thornton & Ross (Huddersfield)
|
| 19 | Viatris UK Healthcare (Hatfield)
|
| 20 | DR Falk Pharma (Bucks)
|
| 21 | Selective Supplies (Haywards Heath)
|
| 22 | Orphalan (London)
|
| 23 | Univar Solutions (Cl Rotterdam)
|
| 24 | Waymade (Basildon)
|
| 25 | Accord (London)
|
| 26 | Gedeon Richter (London)
|
| 27 | Ranbaxy (London)
|
| 28 | Teva (Castleford)
|
| 29 | Thornton & Ross (Huddersfield)
|
| 30 | Galen (Craigavon)
|
| 31 | Norgine Pharmaceuticals (Uxbridge)
|
| 32 | Stirling Anglian Pharmaceuticals (Glasgow)
|
| 33 | Glenmark Pharmaceuticals Europe (Watford)
|
| 34 | Wockhardt (Wrexham)
|
| 35 | Pharmacosmos (Reading)
|
| 36 | Vifor Pharma (Maidenhead)
|
| 37 | Glenmark Pharmaceuticals Europe (Watford)
|
| 38 | Ranbaxy (London)
|
| 39 | Accord (London)
|
| 40 | Aventis Pharma (Guildford)
|
| 41 | Baxter Healthcare (Berkshire)
|
| 42 | Brown & Burk (West London)
|
| 43 | Colonis Pharma (London)
|
| 44 | Crescent Pharma (Basingstoke)
|
| 45 | CST Pharma (Walsall)
|
| 46 | DR Reddys Laboratories (Cambridge)
|
| 47 | Ennogen Healthcare (Dartford)
|
| 48 | Ferring Pharmaceuticals (West Drayton)
|
| 49 | Flynn Pharma (Stevenage)
|
| 50 | Focus Pharmaceuticals (Burton upon Trent)
|
| 51 | Glenmark Pharmaceuticals Europe (Watford)
|
| 52 | Hameln Pharma (Gloucester)
|
| 53 | Kent Pharmaceuticals (Ashford)
|
| 54 | Martindale Pharma (Romford)
|
| 55 | Mercury Pharmaceuticals (London)
|
| 56 | Morningside Pharmaceuticals (Leicester)
|
| 57 | Necessity Supplies (Northolt)
|
| 58 | Panpharma (Liverpool)
|
| 59 | Pfizer (Tadworth)
|
| 60 | Ranbaxy (London)
|
| 61 | Rosemont Pharmaceuticals (Leeds)
|
| 62 | RPH Pharma (Cheadle)
|
| 63 | Sandoz (Camberley)
|
| 64 | Selective Supplies (Haywards Heath)
|
| 65 | Teva (Castleford)
|
| 66 | Typharm (Norwich)
|
| 67 | Waymade (Basildon)
|
| 68 | Wockhardt (Wrexham)
|
| 69 | Wockhardt (Wrexham)
|
| 70 | Otsuka Pharmaceuticals (Windsor)
|
Award Criteria
| Logistics | 5 |
| price | 95 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 28651. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-pr... A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants/contractors agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework/contract. Potential framework participants/contractors are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants/contractors are required to summarise any proposed community benefits that will be developed and delivered as part of this framework/contract if successful or, alternatively, potential framework participants/contractors confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-com...). (SC Ref:804878)
Reference
- ocds-h6vhtk-04e8f9
- FTS 043203-2025